SITC Resource Library

SITC 2019 Annual Meeting: Concurrent Session 309: Single Agent Phase 1 Clinical Trials 

10-24-2019 10:52

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 309: Single Agent Phase 1 Clinical Trials" during the SITC 2019 Annual Meeting on November 9, 2019. Available here are the presentation slides and video from the session.

 

34th Annual Meeting Organizers

  • Ana Carrizosa Anderson, PhD – Harvard Medical School
  • Marianne Davies, DNP, AOCNP – Yale School of Nursing
  • Stefani Spranger, PhD – Koch Institute for Integrative Cancer Research at MIT
  • Ahmad A. Tarhini, MD, PhD – Emory University and Winship Comprehensive Cancer Center


Session Co-Chairs

  • Helen Chen, MD – National Cancer Institute
  • Naiyer Rizvi, MD – Columbia University Medical Center


To view the entire program schedule (including presenter permission to post) please click here.

Statistics
0 Favorited
122 Views
6 Files
0 Shares
236 Downloads
Attachment(s)
pdf file
"Intratumoral INT230-6 injection into solid tumors kills ...   1.46 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Jacob Thomas, MD – USC Norris Comprehensive Cancer Center; Date: November 9, 2019
mp4 file
"Intratumoral INT230-6 injection into solid tumors kills ...   285.00 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Jacob Thomas, MD – USC Norris Comprehensive Cancer Center; Date: November 9, 2019
pdf file
"Single agent anti-tumor activity in PD-1 refractory NSCL...   1.82 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Anthony W. Tolcher, MD, FRCPC – Next Oncology; Date: November 9, 2019
mp4 file
"Single agent anti-tumor activity in PD-1 refractory NSCL...   348.73 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Anthony W. Tolcher, MD, FRCPC – Next Oncology; Date: November 9, 2019
pdf file
"First-in-Class small molecule CA-170 targeting VISTA: A ...   1.16 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Marjorie G. Zauderer, MD, MS, FACP – Memorial Sloan Kettering Cancer Center; Date: November 9, 2019
mp4 file
"First-in-Class small molecule CA-170 targeting VISTA: A ...   203.87 MB   1 version
Uploaded - 12-18-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 309: Single Agent Phase 1 Clinical Trials; Presenter: Marjorie G. Zauderer, MD, MS, FACP – Memorial Sloan Kettering Cancer Center; Date: November 9, 2019

Related Entries and Links

No Related Resource entered.